Daria Stypinski - Concepedia

Author

Daria Stypinski

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

D Stypinski, D. STYPINSKI, D. Stypinski, Daria Stypinski, Stypinski, Daria.

Publications

802

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Celerion (United States)University of Alberta Pfizer (United States)Novartis (Switzerland)

About

Daria Stypinski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	191
2	Engineering	1	1	20
3	Health Sciences	1	1	16
4	Natural Sciences	1	1	75
5	Public Health	1	1	48

Daria Stypinski

Publications

648

Citations

H-Index

Page 1

	Year	Citations
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A Thomayant Prueksaritanont, DA Tatosian, Xiaoyan Chu, Clinical Pharmacology & Therapeutics	2016	129
Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent Joanne M. Donovan, Daria Stypinski, Mark R. Stiles, Cardiovascular Drugs and Therapy	2000	93
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether‐lumefantrine (Riamet<sup>®</sup>) with concomitant administration of ketoconazole in healthy subjects Gilbert Lefèvre, Polly Carpenter, C. Souppart, British Journal of Clinical Pharmacology	2002	83
Fluoroazomycin arabinoside (FAZA): synthesis,2H and3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia Piyush Kumar, Daria Stypinski, Hong Jun Xia, Journal of Labelled Compounds and Radiopharmaceuticals Pharmaceutical ScienceBioorganic ChemistryPharmacotherapyPharmaceutical ChemistryPre-clinical Pharmacology	1999	75
A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products Ebi K. Kimanani, Daria Stypinski, Gary Curtis, The Journal of Clinical Pharmacology Drug SafetyPharmaceutical ResearchDrug DevelopersHealth PolicyIndustry Ba	2000	48
Safety, tolerability and pharmacokinetics of higher‐dose mizoribine in healthy male volunteers Daria Stypinski, Mohammad Obaidi, Michelle D. Combs, British Journal of Clinical Pharmacology	2006	44
Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics Sauzanne Khalilieh, Ka Lai Yee, Rachael Liu, The Journal of Clinical Pharmacology	2016	22
Metabolism, Excretion, and Pharmacokinetics of Lorlatinib (PF‐06463922) and Evaluation of the Impact of Radiolabel Position and Other Factors on Comparability of Data Across 2 ADME Studies Daria Stypinski, Luke Fostvedt, Justine L. Lam, The Journal of Clinical Pharmacology	2020	22
A Single‐Dose, Two‐Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects Steve K. Teo, Michael R. Scheffler, Anfan Wu, The Journal of Clinical Pharmacology NutritionHealthy SubjectsDietary ExposureFood IntakePsychopharmacology	2004	20
Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues. Wiebe Li, Daria Stypinski PubMed EngineeringHypoxia MarkerNeuro-oncologyMedicinal ChemistryTheranostics	1996	20

Page 1